SEC Filing Summary: Nukkleus Inc. (NUKK)
Business Context and Reporting Period
This Form 8-K, dated December 16, 2025, reports the results of a Special Meeting of Stockholders held by Nukkleus Inc. (the "Company"). The filing details the approval of four critical proposals related to capital raising, acquisitions, and securities issuance. As of the record date (November 17, 2025), there were 16,645,766 shares of Common Stock outstanding. A quorum was established with 7,425,406 shares (44.60%) present or represented by proxy.
Key Financial Metrics and Capital Structure
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, or operating margins. Instead, it outlines significant capital structure changes approved by shareholders:
- Acquisition Financing: Approval to acquire 100% of Star Capital 26, Inc. ("Star") via a combination of cash and Company securities.
- Warrant Exercise: Authorization to issue 3,191,400 shares upon exercise of warrants held by accredited investors at an exercise price of $5.405 per share.
- Equity Line of Credit (ELOC): Approval to sell up to $250,000,000 of Common Stock to Esousa Group Holdings, LLC under a purchase agreement dated September 19, 2025.
- Preferred Stock Conversion: Authorization to issue shares upon conversion of Series A Convertible Preferred Stock (initially $10,000,000 aggregate purchase price), which converts into approximately 2,044,800 shares of Common Stock at an initial conversion price of $4.89 per share.
Material Changes and Voting Results
All four proposals were approved by a significant majority of the shares voted at the Special Meeting. The specific voting results were:
- Proposal 1 (Star Acquisition): 99.68% voted FOR (7,394,813 shares).
- Proposal 2 (Warrant Shares): 99.19% voted FOR (7,361,288 shares).
- Proposal 3 (ELOC Issuance): 99.41% voted FOR (7,374,880 shares).
- Proposal 4 (Preferred Stock Conversion): 99.40% voted FOR (7,373,447 shares).
These approvals enable the Company to proceed with significant dilution events required under Nasdaq Listing Rule 5635, as the issuances exceed 19.99% or 20% of the outstanding shares and involve related parties or change of control scenarios.
Outlook, Risks, and Management Commentary
The filing indicates that the Company is actively pursuing growth through the acquisition of Star Capital 26, Inc., where the Company's CEO, Menachem Shalom, is also the controlling shareholder. The approval of the $250 million ELOC and the conversion of Series A Preferred Stock suggests a strategic focus on securing substantial liquidity for operations or further expansion. The filing references a Proxy Statement filed on November 24, 2025, for further details on risks and contingencies associated with these transactions. No specific forward-looking guidance on revenue or earnings was included in this report.
Key Facts for Investor Verification
- Related Party Transaction: Verify the terms of the Star Capital acquisition, noting that CEO Menachem Shalom is a controlling shareholder of the target company.
- Dilution Impact: Assess the total potential share count increase from the ELOC ($250M), warrant exercises (3.19M shares), and preferred stock conversion (2.04M shares).
- Liquidity Terms: Review the specific terms of the Esousa Group ELOC agreement to understand the pricing mechanism and conditions for the $250 million issuance.
- Conversion Triggers: Monitor the adjustment mechanisms for the Series A Preferred Stock conversion price, which is subject to anti-dilution adjustments and market price resets.